// COMPANY
Propel Bio Partners
SECTOR VENTURE CAPITALMENTIONS 1LAST SEEN SEPTEMBER 1, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·PitchBook News·SEPTEMBER 1, 2026
“Biotech startup EIT Pharma, which focuses on infectious disease treatments, secured a $35 million Series A led by Propel Bio Partners.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.